Experience

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by 8x8, Inc. of $287.5 million aggregate principal amount of its 0.50% convertible…

Davis Polk advised the administrative agent, joint lead arrangers, joint bookrunners and senior managing agents, with respect to The Dun & Bradstreet Corporation’s $2.53 billion senior…

Davis Polk advised AC Immune SA in connection with its $117.5 million U.S. follow-on public offering. AC Immune sold 8,500,000 of its newly issued common shares and subscription rights…